Lloyd Curtis
Brentford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 15, 2021
Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study.
Journal: HIV research & clinical practice
Published: November 15, 2021
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.
Journal: AIDS (London, England)
Published: September 17, 2021
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
Journal: AIDS (London, England)
Published: October 13, 2020
Antiretroviral therapy and liver disorders in the OPERA® cohort.
Journal: Therapeutic advances in drug safety
Published: August 10, 2020
Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 29, 2020
Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 07, 2019
Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.
Journal: Therapeutic advances in drug safety
Published: April 04, 2018
Psychiatric Symptoms in Patients Receiving Dolutegravir.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 17, 2016
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Journal: Pharmacoepidemiology and drug safety
Published: March 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026